In conclusion, the present study identified PLOD3 as a novel pro-metastatic factor in lung cancer and as a novel tumor oncogene with an essential role in inducing metastasis, potentially serving as a promising prognostic biomarker for lung cancer. This evidence concerns the gene PLOD3 and neoplasm.